Does Kaiser Cover Zepbound? Criteria, Costs, and Appeals

Kaiser Permanente does cover Zepbound for weight loss, but only when your specific plan includes a benefit for weight loss medications and you meet a demanding set of clinical criteria. Zepbound is non-formulary across Kaiser regions, which means every prescription goes through a clinical review. Most standard Kaiser HMO plans don’t include the weight loss drug benefit at all, so for the majority of members the answer in practice is no.

Whether Your Plan Includes the Benefit

Coverage depends on who bought the plan and what they chose to include.

In the Kaiser Permanente Northwest Region, Zepbound is labeled “non-formulary” and is covered under the prescription drug benefit only for members whose plan specifically includes coverage for weight loss medications.1Kaiser Permanente. Zepbound Coverage Criteria – Northwest Region In Kaiser Southern California, Zepbound doesn’t appear on the 2026 Commercial HMO formulary at all; an unlisted drug can still be covered if a Kaiser doctor determines it is medically appropriate and necessary, but there is no automatic pathway.2Kaiser Permanente. Commercial HMO Formulary – Southern California

Employer-sponsored plans may add the weight loss drug benefit if the employer opted in. Federal Employee Health Benefits and Postal Service Health Benefits plans list GLP-1 medications for weight loss at 50% coinsurance, subject to prior authorization and enrollment in a weight management program.3Kaiser Permanente. Kaiser Permanente PSHB Weight Management Programs and GLP-1 Requirements Individual and ACA marketplace plans generally mirror the base restrictions and exclude Zepbound for weight loss.4FindHonestCare. Zepbound Insurance – Kaiser Permanente Medicare Part D members are explicitly excluded from the Northwest Region’s Zepbound criteria.1Kaiser Permanente. Zepbound Coverage Criteria – Northwest Region

Rules differ by region. Kaiser’s own documents tell members to contact Pharmacy Services in their home region to confirm their benefits for weight loss medications.1Kaiser Permanente. Zepbound Coverage Criteria – Northwest Region

The Clinical Criteria You Have to Clear

Even when the benefit is there, Kaiser imposes significant prior authorization hurdles. The most detailed public criteria come from the Northwest Region, effective August 2025.5Kaiser Permanente. Zepbound Clinical Criteria – Northwest Region Commercial

BMI and Comorbidities

For chronic weight management, you need a BMI of 30 or higher, or a BMI of 27 or higher with at least one qualifying comorbidity: hypertension, diabetes, or high cholesterol. Current weight and BMI must be documented within the previous 30 days. You must be at least 18 and actively participating in a diet and exercise program.1Kaiser Permanente. Zepbound Coverage Criteria – Northwest Region

Step Therapy

Zepbound is not a first-line option. You must document failure of at least two older weight loss medications after trying each for a minimum of three months. The qualifying medications are phentermine, diethylpropion, topiramate, phentermine/topiramate (Qsymia), and naltrexone/bupropion (Contrave). After clearing that step, you must also have tried semaglutide (sold as Wegovy or Ozempic) for at least six months without adequate results, followed by a bariatric medicine chart review to determine whether switching to Zepbound is warranted.5Kaiser Permanente. Zepbound Clinical Criteria – Northwest Region Commercial Documented allergy or intolerance can stand in for a full trial.

Safety Exclusions

Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 are excluded from coverage, consistent with the drug’s FDA labeling.1Kaiser Permanente. Zepbound Coverage Criteria – Northwest Region

Coverage for Obstructive Sleep Apnea

The FDA approved Zepbound in December 2024 to treat moderate-to-severe obstructive sleep apnea in adults with obesity.6Eli Lilly. FDA Approves Zepbound (Tirzepatide) Kaiser Northwest keeps a separate set of criteria for this indication: BMI of 30 or higher, a sleep study from the past three years showing severe sleep apnea (apnea-hypopnea index of 30 or greater), no diagnosis of central or complex apnea, and no more than 5% body weight loss since the sleep study.5Kaiser Permanente. Zepbound Clinical Criteria – Northwest Region Commercial The step therapy requirements are identical to the weight management pathway. New members transferring to Kaiser who are already on Zepbound for sleep apnea can receive 12 months of continued coverage if their plan includes the weight loss medication benefit.1Kaiser Permanente. Zepbound Coverage Criteria – Northwest Region

Renewing After 12 Months

Approval lasts a year. To keep coverage, you must provide updated weight and BMI documentation and show that you have achieved and maintained at least 5% weight loss since starting the medication. Falling short can end coverage.1Kaiser Permanente. Zepbound Coverage Criteria – Northwest Region

What You’ll Pay

Kaiser’s public formulary documents don’t list a specific copay for Zepbound. PSHB members pay 50% coinsurance on GLP-1 drugs.3Kaiser Permanente. Kaiser Permanente PSHB Weight Management Programs and GLP-1 Requirements FEHB members in the Northwest Region pay $80 to $90 for a 30-day supply of a non-preferred brand under the High and Standard options, or 40% coinsurance up to $350 under the Prosper option.7Kaiser Permanente. Federal Employees Health Benefits Formulary – Northwest Region Everyone else should check their plan’s evidence of coverage document.

Members whose plans don’t cover weight loss drugs are told they can pay the “member cash price” at Kaiser pharmacies.1Kaiser Permanente. Zepbound Coverage Criteria – Northwest Region The exact Kaiser cash price isn’t published; the standard retail list price for Zepbound is approximately $1,086 per month.8CNBC. Eli Lilly Prices Zepbound Weight Loss Drug Vials

The Lilly Savings Card at Kaiser

Eli Lilly offers a savings card that can bring Zepbound down to as little as $25 per month for patients with commercial insurance that covers the drug.9Eli Lilly. LillyDirect – Zepbound Kaiser doesn’t accept all manufacturer coupons, and Zepbound isn’t on the list of medications eligible for manufacturer coupon use at Kaiser pharmacies.10Kaiser Permanente. Drug Manufacturer Coupons The Lilly savings card generally can’t be applied at Kaiser’s internal pharmacies.

If You’re Denied

You can start an internal grievance by calling the number on your member ID card. Build the appeal around complete weight and BMI history, documentation of comorbidities with diagnostic codes, records of all prior weight loss interventions (lifestyle programs and medications), and a letter of medical necessity from the prescribing physician. Clinical trial data and professional society guidelines strengthen the case.

If the internal appeal fails, California members can file a complaint with the Department of Managed Health Care and request an Independent Medical Review, conducted by physicians not employed by Kaiser.11HealthRx. Kaiser Permanente Coverage – Zepbound In other states, contact your state insurance regulator for the equivalent process.

Options When Kaiser Won’t Cover It

  • LillyDirect sells Zepbound directly to patients. As of late 2025, single-dose vials run $299 per month for the 2.5 mg starting dose, $399 for 5 mg, and $449 for doses from 7.5 mg through 15 mg. These prices require refilling within 45 days; higher rates apply otherwise.9Eli Lilly. LillyDirect – Zepbound8CNBC. Eli Lilly Prices Zepbound Weight Loss Drug Vials
  • Mounjaro uses the same molecule, tirzepatide. If you have type 2 diabetes, a Kaiser endocrinologist may be able to prescribe Mounjaro under diabetes coverage. Mounjaro is also non-formulary in the Northwest Region and has its own coverage criteria tied to diabetes treatment.12Kaiser Permanente. Mounjaro Coverage Criteria – Northwest Region
  • Zepbound is an eligible expense for Health Savings Accounts and Flexible Spending Accounts, which can offset part of the cash cost.

Pending California Legislation

California Assembly Bill 575, the “Obesity Prevention Treatment Parity Act,” would have required health plans in the state to cover at least one FDA-approved anti-obesity medication, including GLP-1 drugs like Zepbound, without prior authorization. The bill failed in the 2025–2026 legislative session, so California law continues to require coverage of prescription drugs for obesity only when a patient is diagnosed with severe (morbid) obesity.13LegiScan. California AB 575 – Amended Text A companion bill, Senate Bill 535, was also under consideration but did not change the current landscape. If you’re planning around Kaiser coverage in California, the rules above still apply.